Merck & Co. Inc. (MRK)
-NYSE 47.91 
0.58(1.23%) 00:03 SGT - Nasdaq Real Time Price
| Prev Close: | 47.33 |
|---|
| Open: | 47.60 |
|---|
| Bid: | 48.01 x 3500 |
|---|
| Ask: | 48.02 x 1700 |
|---|
| 1y Target Est: | 50.11 |
|---|
| Beta: | 0.39 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 47.54 - 48.30 |
|---|
| 52wk Range: | 37.02 - 48.79 |
|---|
| Volume: | 18,260,757 |
|---|
| Avg Vol (3m): | 16,795,600 |
|---|
| Market Cap: | 144.67B |
|---|
| P/E (ttm): | 24.50 |
|---|
| EPS (ttm): | 1.96 |
|---|
| Div & Yield: | 1.72 (3.70%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Merck signs $5 billion share buyback agreement with Goldman SachsReuters(Wed, 22 May)
- Merck to repurchase $5B in common stockAP(Wed, 22 May)
- FDA has safety concerns with Merck insomnia drugAP(Mon, 20 May)
- FDA has safety concerns on Merck insomnia drugAP(Mon, 20 May)
- Moody's lowers Merck's long-term debt ratingAP(Wed, 15 May)
- Higher prices for MS drug help drug firm MerckAP(Tue, 14 May)
- Drugmakers, health groups bring poor girls vaccineAP(Fri, 10 May)
- Lawsuit alleges Merck discriminates against womenAP(Fri, 10 May)
- Merck: FDA reviewing its ragweed allergy therapyAP(Thu, 9 May)
- Merck plays up consumer products in new campaignAP(Tue, 7 May)
- Theravance Narrows Y/Y LossZacks(Wed, 13 Feb)
- Cardiome Selects QuintilesZacks(Wed, 13 Feb)
- UPS Expands in Health Care MarketsZacks(Fri, 8 Feb)
- Merck Beats, Issues OutlookZacks(Fri, 1 Feb)
- Pipeline Progress at EndocyteZacks(Fri, 1 Feb)
Key Statistics
| Forward P/E (1 yr): | 12.67 |
|---|
| P/S (ttm): | 3.09 |
|---|
| Ex-Dividend Date: | 13-Mar-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.51 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.84 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 5.22 |
|---|
Business Summary
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
View More